Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

The Herman B. Wells Center for Pediatric Research at the Indiana University School of Medicine has appointed Raghu Mirmira director. His research has led to the discovery and characterization of fast-acting insulin analogues, which are widely used by patients with diabetes. Mirmira currently serves as Eli Lilly and Co. professor of pediatric diseases, director of the Center for Diabetes and Metabolic Diseases, professor of pediatrics and medicine and adjunct professor of physiology and biochemistry. He received his BA in chemistry and his doctorate in philosophy, biochemistry and molecular biology. Mirmira also earned his doctor of medicine from the University of Chicago. 

Story Continues Below

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Upgrade Now

Big business news. Teeny tiny price. $1/week Upgrade Now

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In